Enhancing cellular uptake of activable cell-penetrating peptide–doxorubicin conjugate by enzymatic cleavage
Authors:
- Xian-Rong QiXQXian-Rong Qi
- Wei GaoWGWei Gao
- Bai XiangBXBai Xiang
Open Access
- 1 March 2012
- journal article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 7, 1613-21
Abstract
Peer reviewed article authored by (Shi NQ, Gao W, Xiang B, Qi XR). Read article or submit your manuscript for publishing.Keywords
This publication has 38 references indexed in Scilit:
- Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231Cancer Letters, 2009
- Recent advances in the use of cell-penetrating peptides for medical and biological applications☆Advanced Drug Delivery Reviews, 2009
- Proteolysis: A Biological Process Adapted in Drug Delivery, Therapy, and ImagingBioconjugate Chemistry, 2009
- Cell-penetrating and cell-targeting peptides in drug deliveryBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2008
- Progress in matrix metalloproteinase researchMolecular Aspects of Medicine, 2008
- Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transportersProceedings of the National Academy of Sciences, 2008
- Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavageInternational Journal of Nanomedicine, 2008
- Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free mediumLife Sciences, 2008
- Overcoming methotrexate resistance in breast cancer tumour cells by the use of a new cell-penetrating peptideBiochemical Pharmacology, 2006
- Synthesis of doxorubicin–peptide conjugate with multidrug resistant tumor cell killing activityBioorganic & Medicinal Chemistry Letters, 2005